# Marker Therapeutics, Inc.: Form 8-K, filed Jan 30, 2025

- Company: [Marker Therapeutics, Inc.](/companies/mrkr.md) (CIK 1094038)
- Form: 8-K
- Filed: 2025-01-30
- Accepted by EDGAR: Jan 30, 2025, 21:05 ET
- Period: 2025-01-24
- Accession: 0001104659-25-007574
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1094038/000110465925007574/tm254924d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1094038/000110465925007574/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1094038/000110465925007574/tm254924d1_8k.htm

Filed Jan 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-007574. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.